admin

In this article BTC.CM= Follow your favorite stocksCREATE FREE ACCOUNT Thomas Trutschel | Photothek | Getty Images The board of Acurx Pharmaceuticals approved Wednesday the purchase of up to $1 million in bitcoin to hold as a treasury reserve asset. Shares of the the company were last lower by more than 6% after spiking about
In this article HSIC Follow your favorite stocksCREATE FREE ACCOUNT Robert F. Kennedy Jr. attends a campaign event for Republican presidential nominee and former U.S. President Donald Trump in Milwaukee, Wisconsin, U.S. November 1, 2024.  Joel Angel Juarez | Reuters Dental care supplier Henry Schein advanced in Monday trading as investors bet that Robert F.
Tom Yeung here with your Sunday Digest.  Last week, I recommended five stocks to buy in 2025 on a Donald Trump election victory. The president-elect is known for his clear intentions, and his second term promises even more of what we saw during his first 2016-2020 go-around. (I realize some of you will love this
In this article META Follow your favorite stocksCREATE FREE ACCOUNT Jonathan Raa | Nurphoto | Getty Images Company: Meta Platforms (META) Business: Meta Platforms builds technologies that help people find communities and grow businesses. The company’s products enable people to connect and share with friends and family through mobile devices, personal computers, virtual reality headsets,
In this article MSFT CEG Follow your favorite stocksCREATE FREE ACCOUNT Cooling towers at the Three Mile Island nuclear power plant in Middletown, Pennsylvania, Oct. 30, 2024. Danielle DeVries | CNBC MIDDLETOWN, Pa. — The owner of the Three Mile Island nuclear power plant is embarking on an ambitious plan to restart operations before the
Cathie Wood, CEO of Ark Invest, speaks during an interview on CNBC on the floor of the New York Stock Exchange (NYSE) in New York City, February 27, 2023. Brendan McDermid | Reuters Cathie Wood is defending her underperforming ARK Innovation exchange traded fund following a rocky stretch. “We have a volatile fund,” she told
U.S. Securities and Exchange Commission Chair Gary Gensler testifies before a House Financial Services Committee oversight hearing on Capitol Hill in Washington, D.C., on Sept. 27, 2023. Jonathan Ernst | Reuters Securities and Exchange Commission Chairman Gary Gensler spoke this morning at the Practising Law Institute’s 56th annual conference on securities regulation.  It sounded awfully
In this article GLRE Follow your favorite stocksCREATE FREE ACCOUNT David Einhorn, President at Greenlight Capital, speaking at the 14th CNBC Delivering Alpha Investor Summit in New York City on Nov. 13th, 2024. Adam Jeffery | CNBC Greenlight Capital’s David Einhorn was interviewed by our Leslie Picker at CNBC’s Delivering Alpha event Wednesday.  Einhorn spoke
In this article BTC.CM= BLK Follow your favorite stocksCREATE FREE ACCOUNT The BlackRock logo is pictured outside the company’s headquarters in the Manhattan borough of New York City on May 25, 2021. Carlo Allegri | Reuters BlackRock has expanded its tokenized money market fund to include several more blockchains. The investment manager said Wednesday that
The stock market could enjoy a bigger boost from President-elect Donald Trump than any previous administration thanks to his pro-business policies, according to Jeremy Siegel, finance professor at the Wharton School of the University of Pennsylvania. “President-elect Trump is the most pro-stock market president we have had in our history,” Siegel said on CNBC’s “Squawk Box”
Tom Yeung here with your Sunday Digest.   On November 6, we finally got our answer…  Donald Trump will be the 47th president of the United States of America.  Half of all Americans are delighted. Trump has promised everything from lower taxes to stricter migration rules, and Congress appears in a position to let him
In this article VRP-GB Follow your favorite stocksCREATE FREE ACCOUNT Rafael Henrique | SOPA Images | AP Company: Verona Pharma (VRNA) Business: Verona Pharma, a clinical stage biopharmaceutical company, focuses on development and commercialization of therapies for the treatment of respiratory diseases with unmet medical needs. The company’s product candidate is ensifentrine, an inhaled and